Clinical trial
Randomised Evaluation of COVID-19 Therapy
NCT04381936 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Evaluation of COVID-19 Therapy
- Lead sponsor
- University of Oxford
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- March 19, 2020
- Completion date
- September 30, 2038
- Enrollment
- 70,000 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.